Adiponectin Deficiency Promotes the Production of Inflammatory Mediators While Severely Exacerbating Hepatic Injury in Mice with Polymicrobial Sepsis

Journal of Surgical Research

Volumn 161, Issue 2, 2010, Pages 301-311

  Uji, Yoshitaka ^a   Yamamoto, Hiroshi ^a   Maeda, Kazuhisa ^b   Tsuchihashi, Hiroshi ^a   Akabori, Hiroya ^a   Shimizu, Tomoharu ^a   Endo, Yoshihiro ^a   Shimomura, Iichiro ^b   Tani, Tohru ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

adiponectin; hepatic injury; monocyte chemoattractant protein 1; peroxisome proliferator activated receptor gamma; sepsis

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; ROSIGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; HISTOPATHOLOGY; KNOCKOUT MOUSE; LIVER CELL; LIVER INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEPSIS; WILD TYPE;

ADIPONECTIN; ALANINE TRANSAMINASE; ANIMALS; DISEASE MODELS, ANIMAL; FIBRINOLYTIC AGENTS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; PUNCTURES; RECEPTORS, CCR2; SEPSIS; SHOCK, SEPTIC; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951938365     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.12.021     Document Type: Article

References (60)

1. Martin G.S., Mannino D.M., Eaton S., and Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348 (2003) 1546
2. Annane D., Bellissant E., and Cavaillon J.M. Septic shock. Lancet 365 (2005) 63
3. Bossink A.W., Paemen L., Jansen P.M., et al. Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood 86 (1995) 3841
4. Hack C.E., Hart M., van Schijndel R.J., et al. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 60 (1992) 2835
5. Casey L.C., Balk R.A., and Bone R.C. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119 (1993) 771
6. Ghosh S., Latimer R.D., Gray B.M., et al. Endotoxin-induced organ injury. Crit Care Med 21 Suppl2 (1993) S19
7. Deans K.J., Haley M., Natanson C., et al. Novel therapies for sepsis: a review. J Trauma 58 (2005) 867
8. Speyer C.L., Gao H., Rancilio N.J., et al. Novel chemokine responsiveness and mobilization of neutrophils during sepsis. Am J Pathol 165 (2004) 2187
9. Yamaguchi Y., Matsumura F., Takeya M., et al. Monocyte chemoattractant protein-1 enhances expression of intercellular adhesion molecule-1 following ischemia-reperfusion of the liver in rats. Hepatology 27 (1998) 727
10. Bozza F.A., Salluh J.I., Japiassu A.M., et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 11 (2007) R49
11. Vachharajani V., and Vital S. Obesity and sepsis. J Intensive Care Med 21 (2006) 287
12. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79
13. Kubota N., Terauchi Y., Yamauchi T., et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277 (2002) 25863
14. Kumada M., Kihara S., Sumitsuji S., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23 (2003) 85
15. Ouchi N., and Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta 380 (2007) 24
16. Teoh H., Quan A., Bang K.W., et al. Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality. Am J Physiol Endocrinol Metab 295 (2008) E658
17. Tsuchihashi H., Yamamoto H., Maeda K., et al. Circulating concentrations of adiponectin, an endogenous lipopolysaccharide neutralizing protein, decrease in rats with polymicrobial sepsis. J Surg Res 134 (2006) 348
18. Xu A., Wang Y., Keshaw H., et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112 (2003) 91
19. Masaki T., Chiba S., Tatsukawa H., et al. Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. Hepatology 40 (2004) 177
20. Maeda N., Takahashi M., Funahashi T., et al. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50 (2001) 2094
21. Liu D., Zeng B.X., Zhang S.H., et al. Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, reduces acute lung injury in endotoxemic rats. Crit Care Med 33 (2005) 2309
22. Maeda N., Shimomura I., Kishida K., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8 (2002) 731
23. Chaudry I.H., Wichterman K.A., and Baue A.E. Effect of sepsis on tissue adenine nucleotide levels. Surgery 85 (1979) 205
24. Kiank C., Koerner P., Kessler W., et al. Seasonal variations in inflammatory responses to sepsis and stress in mice. Crit Care Med 35 (2007) 2352
25. Bhathena S.J., Ali A.A., Haudenschild C., et al. Dietary flaxseed meal is more protective than soy protein concentrate against hypertriglyceridemia and steatosis of the liver in an animal model of obesity. J Am Coll Nutr 22 (2003) 157
26. Ahima R.S. Adipose tissue as an endocrine organ. Obesity (Silver Spring) 14 (2006) 242S
27. Ouchi N., Kihara S., Funahashi T., et al. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 14 (2003) 561
28. Maeda K., Okubo K., Shimomura I., et al. Analysis of an expression profile of genes in the human adipose tissue. Gene 190 (1997) 227
29. Matsuzawa Y., Funahashi T., Kihara S., et al. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 24 (2004) 29
30. Whitehead J.P., Richards A.A., Hickman I.J., et al. Adiponectin - a key adipokine in the metabolic syndrome. Diabetes Obes Metab 8 (2006) 264
31. Yokota T., Oritani K., Takahashi I., et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96 (2000) 1723
32. Wulster-Radcliffe M.C., Ajuwon K.M., et al. Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun 316 (2004) 924
33. Leuwer M., Welters I., Marx G., et al. Endotoxaemia leads to major increases in inflammatory adipokine gene expression in white adipose tissue of mice. Pflugers Arch (2008) (Epub ahead of print)
34. Fink M.P., and Heard S.O. Laboratory models of sepsis and septic shock. J Surg Res 49 (1990) 186
35. Ajuwon K.M., and Spurlock M.E. Adiponectin inhibits LPS-induced NF-κB activation and IL-6 production and increases PPARγ2 expression in adipocytes. Am J Physiol Regul Inteqr Comp Physiol 288 (2005) R1220
36. Peake P.W., Shen Y., Campbell L.V., et al. Human adiponectin binds to bacterial lipopolysaccharide. Biochem Biophys Res Commun 341 (2006) 108
37. Matsumoto H., Tamura S., Kamada Y., et al. Adiponectin deficiency exacerbates lipopolysaccharide/D-galactosamine-induced liver injury in mice. World J Gastroenterol 12 (2006) 3352
38. Hawker F. Liver dysfunction in critical illness. Anaesth Intensive Care 192 (1991) 165
39. Harbrecht B.G., Wu B., Watkins C., Billiar T.R., and Peitzman A.B. Inhibition of nitric oxide synthesis during severe shock but not after resuscitation increases hepatic injury and neutrophil accumulation in hemorrhaged rats. Shock 86 (1997) 415
40. Burt A.D., Portmann B.C., and Ferrell L.D. MacSween's Pathology of the Liver. 5th ed. (2007), Elsevier, Edinburgh p.84
41. Burt A.D., Mutton A., and Day C.P. Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 15 (1998) 246
42. Deutschman C.S., Cereda M., Ochroch E.A., et al. Sepsis-induced cholestasis, steatosis, hepatocellular injury, and impaired hepatocellular regeneration are enhanced in interleukin-6 -/- mice. Crit Care Med 34 (2006) 2613
43. Yin M., Wheeler M.D., Kono H., et al. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 117 (1999) 942
44. Leist M., Gantner F., Bohlinger I., et al. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 146 (1995) 1220
45. Ramnath R.D., Ng S.W., Guglielmotti A., et al. Role of MCP-1 in endotoxemia and sepsis. Int Immunopharmacol 8 (2008) 810
46. Leonard E.J., and Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 11 (1990) 97
47. Ueda A., and Yoshimura T. Characterization of cis-acting elements of the gene for macrophage-stimulating protein from the human. The involvement of positive and negative regulatory elements. J Biol Chem 271 (1996) 20265
48. Kanda H., Tateya S., Tamori Y., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116 (2006) 1494
49. Clément S., Juge-Aubry C., Sgroi A., et al. Monocyte chemoattractant protein-1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes. Hepatology 48 (2008) 799
50. Zhang H., Zhi L., Moochhala S., et al. Hydrogen sulfide acts as an inflammatory mediator in cecal ligation and puncture induced sepsis in mice by up-regulating the production of cytokines and chemokines via NF-κB. Am J Physiol Lung Cell Mol Physiol 292 (2007) L960
51. Craja M.J., Greets A., Xu J., et al. Monocyte chemoattractant protein-1(MCP-1) expression occurs in toxic rat liver injury and human liver disease. J Leukoc Biol 55 (1994) 120
52. Marra F., DeFranco R., Grappone C., et al. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am J Pathol 152 (1998) 423
53. Dong W., Simeonova P.P., Gallucci R., et al. Cytokine expression in hepatocytes: Role of oxidant stress. J Interferon Cytokine Res 18 (1998) 629
54. Hisama N., Yamaguchi Y., Ishiko T., et al. Kupffer cell production of cytokine-induced neutrophil chemoattractant following ischemia/reperfusion injury in rats. Hepatology 24 (1996) 1193
55. Lázár Jr. G., Paszt A., Kaszaki J., et al. Kupffer cell phagocytosis blockade decreases morbidity in endotoxemic rats with obstructive jaundice. Inflamm Res 51 (2002) 511
56. Leifeld L., Dumoulin F.L., Purr I., et al. Early up-regulation of chemokine expression in fulminant hepatic failure. J Pathol 199 (2003) 335
57. Zhang P., Xie M., Zagorski J., and Spitzer J.A. Attenuation of hepatic neutrophil sequestration by anti-CINC antibody in endotoxic rats. Shock 4 (1995) 262
58. Matsukawa A., Hogaboam C.M., Lukacs N.W., et al. Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4. J Immunol 163 (1999) 6148
59. Yki-Jarvinen H. Thiazolidinediones. N Engl J Med 351 (2004) 1106
60. Liu D., Zeng B.X., Zhang S.H., et al. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor-γ, reduces pulmonary inflammatory response in a rat model of endotoxemia. Inflamm Res 54 (2005) 464